Long-term outcomes following early infection and inflammation in cystic fibrosis lung disease

No Thumbnail Available
File version
Author(s)
Frayman, K
Armstrong, D
Grimwood, K
Wilson, J
Kotsimbos, T
Keating, D
Ranganathan, S
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2021
Size
File type(s)
Location

Virtual

License
Abstract

Introduction/Aim: Infection is critical to cystic fibrosis (CF) lung disease pathogenesis. We explored the impact of lower airway infection with Staphylococcus aureus prior to age 24-months and with Pseudomonas aeruginosa prior to age 60-months on survival and rate of decline of lung function over 25-years.

Methods: A birth cohort of infants newly-diagnosed with CF was established in Melbourne, Australia in 1992. Anti-staphylococcal prophylaxis was not practiced. Bronchoalveolar lavage was performed at study entry and semi-annually thereafter.

A follow-up study was designed. Data were collected from hospital records and the Australian Cystic Fibrosis Data Registry. Survival analyses used Kaplan Meier curves and Cox proportional hazard models. FEV1% predicted annual rate of decline was estimated using linear mixed-effects modelling.

Results: Seventy-nine of 100 original birth cohort members (45.6% male), participated in this follow-up. Lower airway samples (n=221) were collected at median 20.3-months (25th-75th%ile 9.8-30.5-months). Twenty-nine (36.7%) participants were deceased and/or underwent lung transplantation. Survivors (n=50, 63.3%) were of median age 24.9-years (25th-75th%ile 23.3-26.2-years) at the study conclusion.

S. aureus prior to age 24-months was not associated with reduced survival, FEV1% predicted at age 5-years (+0.15, 95% CI -7.91-8.2) or annual rate of FEV1% predicted decline (+0.09%, 95% CI -0.81-0.99). Early P. aeruginosa infection was associated with reduced survival (p=0.015), reduced FEV1 at age 5-years (-4.37%, 95%CI 12.53-3.81) and increased rate of annual FEV1% predicted decline (-0.49, 95%CI -1.37-0.39).

Conclusion: In this first birth cohort of infants with CF diagnosed by newborn screening and treated symptomatically, infection with S. aureus in the first 2-years had no impact on 25-year outcomes. Infection with P. aeruginosa was associated reduced survival and poorer longitudinal lung function. These findings, together with emerging understanding of the potential long-term benefits of microbial diversity, highlight the urgent need for careful evaluation of current approaches to anti-staphylococcal prophylaxis in newly-diagnosed infants.

Journal Title
Conference Title

Respirology

Book Title
Edition
Volume

26

Issue

S2

Thesis Type
Degree Program
School
DOI
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject

Biomedical and clinical sciences

Health sciences

Science & Technology

Life Sciences & Biomedicine

Respiratory System

Persistent link to this record
Citation

Frayman, K; Armstrong, D; Grimwood, K; Wilson, J; Kotsimbos, T; Keating, D; Ranganathan, S, Long-term outcomes following early infection and inflammation in cystic fibrosis lung disease, Respirology, 2021, 26, pp. 22-22